Current status of Kampo (Japanese herbal) medicines in Japanese clinical practice guidelines

Complementary Therapies in Medicine

Volumn 17, Issue 3, 2009, Pages 147-154

  Motoo, Yoshiharu ^a,b,c   Arai, Ichiro ^a,d   Hyodo, Ichinosuke ^a,b,e   Tsutani, Kiichiro ^a,b,f  

^a Japan Society for Oriental Medicine (JSOM)   (Japan)

^b Japanese Liaison of Oriental Medicine (JLOM)   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d Japan Kampo Medicine Manufacturers Association   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Clinical practice guidelines; Evidence based medicine; Herbal medicine; Japan; Kampo; Randomized controlled trials; Traditional medicine

Indexed keywords

ACETYLSALICYLIC ACID; BAKUMONDOTO; CHOTOSAN; GOSHUYUTO; HACHIMIJIOGAN GOSHAJINKIGAN; HERBACEOUS AGENT; KAKKONTO; KAMISHOYOSAN; KAMPO; KEISHI BUKURYO GAN; KEISHININJINTO; RIKKUNSHITO; SAIBOKUTO; SHO SEIRYU TO; TOKISHAKUYAKU SAN; UNCLASSIFIED DRUG; XIAO CHAI HU TANG; YOKUKANSAN;

ARTICLE; ASTHMA; BEHAVIOR DISORDER; CATARACT; CHRONIC PAIN; CLINICAL TRIAL; COUGHING; DATA BASE; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG INFORMATION; DRUG RESEARCH; DRUG SAFETY; DYSPEPSIA; EDEMA; EVIDENCE BASED MEDICINE; HEADACHE; HERBAL MEDICINE; HUMAN; HYPERSENSITIVITY; INFORMATION RETRIEVAL; JAPAN; LIVER CELL CARCINOMA; MENOPAUSAL SYNDROME; MENTAL DISEASE; PERENNIAL RHINITIS; PRACTICE GUIDELINE; SYSTEMATIC REVIEW; TENSION HEADACHE; URTICARIA; VASCULAR DISEASE;

CLINICAL TRIALS AS TOPIC; DRUGS, CHINESE HERBAL; EVIDENCE-BASED MEDICINE; HUMANS; JAPAN; MEDICINE, KAMPO; PHYTOTHERAPY; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TERMINOLOGY AS TOPIC;

EID: 67349084086     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2008.09.003     Document Type: Article

References (50)

1. Oxman A.D., Lavis J.N., and Fretheim A. Use of evidence in WHO recommendations. Lancet 369 9576 (2007) 1883-1889
2. Simon J., and Thea D.M. Use of evidence in WHO recommendations. Lancet 370 9590 (2007) 824-825 author reply 826-7
3. Quigley E.M., Fried M., and Krabshuis J.H. Use of evidence in WHO recommendations. Lancet 370 9590 (2007) 824 author reply 826-7
4. Elliott J.H., and Gruen R.L. Use of evidence in WHO recommendations. Lancet 370 9590 (2007) 826 author reply 826-7
5. Kelly J., Campbell H., Bar-Zeev N., Tamburlini G., and Duke T. Use of evidence in WHO recommendations. Lancet 370 9590 (2007) 825-826 author reply 826-7
6. Peterson H.B., Curtis K.M., Glasier A., and Hagenfeldt K. Use of evidence in WHO recommendations. Lancet 370 9590 (2007) 826-827 author reply 826-7
7. Cassileth B.R., Deng G.E., Gomez J.E., Johnstone P.A., Kumar N., and Vickers A.J. American College of Chest Physicians: complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 3 Suppl. (2007) 340S-354S
8. Ketola E., Kaila M., and Honkanen M. Guidelines in context of evidence. Quality and Safety in Health Care 16 4 (2007) 308-312
9. Tsutani K. The evaluation of herbal medicines: an east Asian perspective. In: Lewith G.T., and Aldridge D. (Eds). Clinical research methodology for complementary therapies (2003), Hodder & Stoughton, Ltd., London, UK 365-393
10. The AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality and Safety in Health Care 12 1 (2003) 18-23
11. http://www.agreecollaboration.org/.
12. Burgers J.S., Fervers B., Haugh M., Brouwers M., Browman G., Philip T., et al. International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument. Journal of Clinical Oncology 22 10 (2004) 2000-2007
13. Motoo Y., and Tsutani K. Is it possible to develop "global" clinical practice guidelines for traditional medicine?. Nihon Toyo Igaku Zasshi (Kampo Medicine) 57 4 (2006) 465-475 [in Japanese with English abstract]
14. Cottler L.B., and Grant B.F. Characteristics of nosologically informative data sets that address key diagnostic issues facing the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V) and International Classification of Diseases, eleventh edition (ICD-11) substance use disorders workgroups. Addiction 101 Suppl. 1 (2006) 161-169
15. Regulations of Kampo extract formulations for prescription. Notification No. 120 of the Second Evaluation and Registration Division, Pharmaceutical Affairs Bureau, Ministry of Health of Japan, dated 31 May 1985.
16. Tsutani K, Daitai Iryo to Keizai: 3.5 Cho-en no Nakami (CAM and Economy in Japan: Contents of US$ 35 Bill). Ido-no-Nihon; in press.
17. Oka H., Yamamoto S., Kuroki T., and Kuroki T. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 76 5 (1995) 743-749
18. Harasawa S., Miyoshi A., Miwa T., Masamune O., Matuso Y., Mori H., et al. Effect of rikkunshito on dysmotility-like dyspepsia: a multi-center, double-blind, randomized trial. Igaku No Ayumi (Journal of Clinical and Experimental Medicine) 187 3 (1998) 207-229 [in Japanese]
19. Kimura T., Akamatsu T., and Yanaihara T. Kampo therapy for climacteric syndrome. Kampo To Saishin Chiryo (Kampo and Newest Therapy) 1 3 (1992) 229-236 [in Japanese]
20. Kimura T., and Yanaihara T. Kampo treatment for climacteric disorder. Sanfujinka Chiryo (Obstetrical and Gynecological Therapy) 63 2 (1991) 199-202 [in Japanese]
21. Murata T. Kampo therapy for climacteric disorder. Current Therapy 8 1 (1990) 47-53 [in Japanese]
22. Obazawa H. Indication of Kampo medicine for eye diseases: cataract. Iyaku Jyanaru (Medicine and Drug Journal) 26 9 (1990) 1853-1856 [in Japanese]
23. Baba S., Takasaka T., Inamura N., Sato M., Suzuki S., Endo S., et al. Double-blind clinical trial of Sho-seiryu-to (TJ-19) for perennial nasal allergy. Jibi-Inkoka Rinsho (Practica Oto-Rhino Laryngologica) 88 3 (1995) 389-405 [in Japanese with English abstract]
24. Watanabe N., Cheng G., and Fukuda T. Effects of Bakumondo-to (Mai-Men-Dong-Tang) on cough sensitivity to capsaicin in asthmatic patients with cough hypersensitivity. Arerugi (Japanese Journal of Allergology) 52 5 (2003) 485-491 [in Japanese with English abstract]
25. Nishizawa Y., Nishizawa Y., Yoshioka F., and Nagano F. Suppressive effect of Japanese herbal medicine, Saiboku-to (Cai-Pu-Tang) on bronchospasms in aspirin-induced bronchial asthmatic patients-a randomized, double-blind test. Jibi-Inkoka Tembo (Oto-Rhino-Laryngology, Tokyo) 44 Suppl. 1 (2001) 5-13 [in Japanese with English abstract]
26. Nishizawa Y., Nishizawa Y., Yoshioka F., Nosaka S., Amenomori Y., Amakata Y., et al. Clinical effect of a Chinese traditional herbal medicine, Cai-Pu-Tang (Japanese name: Saiboku-to) compared with Clotiazepam in patients with bronchial asthmatics and anxiety disorder in multi-center randomized, comparative trial. Nihon Toyo Shinshin-Igaku Kenkyu (Journal of Japanese Association of Oriental Psychomatic Medicine) 17 1-2 (2002) 20-27 [in Japanese with English abstract]
27. Maeda K., Miyagi A., and Sugawara T. Effect of goshuyuto on chronic headache. Kampo Igaku (Science of Kampo Medicine) 22 2 (1998) 53-57 [in Japanese]
28. Akamine M., Hyodo Y., Ashihara M., Sata A., Tsutsumi M., Kosugi M., et al. Usefulness of goshuyuto on tension headache. Nihon Toyo Shinshin-Igaku Kenkyu (Journal of Japanese Association of Oriental Psychomatic Medicine) 15 1-2 (2000) 36-38 [in Japanese]
29. Seki H., Okita T., Takase S., and Matsuda K. Effect of goshuyuto on chronic headache: randomized comparison with keishininjinto. Pharma Medica (The Review of Medicine and Pharmacology) 11 12 (1993) 288-291 [in Japanese]
30. Matsumoto H., Kashiwagi M., Matsuya M., Chiba S., Hashimoto S., Narasaki Y., et al. Study on the usefulness of keishininjinto and chotosan on chronic headache. Rinsho To Kenkyu (The Japanese Journal of Clinical and Experimental Medicine) 72 5 (1995) 1299-1303 [in Japanese]
31. Kimura I., and Saso S. Clinical effect of chotosan on chronic headache in patients with cerebrovascular disorders. Nippon Ronen Igaku Zasshi (Japanese Journal of Geriatrics) 27 3 (1989) 445-449 [in Japanese]
32. Takata O. Efficacy of chotosan on chronic tension headache. Kampo Igaku (Science of Kampo Medicine) 22 4 (1998) 121-124 [in Japanese]
33. Yamamoto M. Clinical effect of kakkonto on chronic tension headache due to stiffness of neck and shoulder. Rinsho To Kenkyu (The Japanese Journal of Clinical and Experimental Medicine) 72 8 (1995) 2085-2088 [in Japanese]
34. Odaguchi H., Wakasugi A., Ito H., Shoda H., Gono Y., Sakai F., et al. The efficacy of goshuyuto, a typical Kampo (Japanese herbal medicine) formula, in preventing episodes of headache. Current Medical Research and Opinion 22 8 (2006) 1587-1597
35. Nishizawa Y., Nishizawa Y., Yoshioka F., Yamada M., Yasuda R., Hirata Y., et al. Effect of Japanese herbal medicine, Shimpi-to (Shen-bi-tang) inhalation therapy on bronchospasms in aspirin-induced bronchial asthmatic patients, compared with sodium cromoglicate-a multi-centered, randomized trial. Jibi-Inkoka Tembo (Oto-Rhino-Laryngology, Tokyo) 46 (2003) 3-14 [in Japanese with English abstract]
36. Iwasaki K., Satoh-Nakagawa T., Maruyama M., Monma Y., Nemoto M., Tomita N., et al. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-gan san for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. Journal of Clinical Psychiatry 66 (2005) 248-252
37. Dubois C.P.R. Free text versus controlled vocabulary: a reassessment. Online Review 11 10 (1987) 243-253
38. Tsutani K, Satake M, Toriizuka K, Hikiami H, Yamada K, Standard Kampo Formula Nomenclature. Nihon Toyo Igaku Zasshi (Kampo Medicine) 2005;56(4):611-22 [in Japanese] (http://www.jsom.or.jp/pdf/standard_kampo.pdf).
39. Kumar N.B., Allen K., and Bell H. Perioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening. Cancer Control 12 3 (2005) 149-157
40. Critchley J.A., Zhang Y., Suthisisang C.C., Chan T.Y., and Tomlinson B. Alternative therapies and medical science: designing clinical trials of alternative/complementary medicines-is evidence-based traditional Chinese medicine attainable?. Journal of Clinical Pharmacology 40 5 (2000) 462-467
41. Gogtay N.J., Bhatt H.A., Dalvi S.S., and Kshirsagar N.A. The use and safety of non-allopathic Indian medicines. Drug Safety 25 14 (2002) 1005-1019
42. Liu J.P. Methodological quality assessment of clinical trials in traditional Chinese medicine: the principles of evidence-based medicine. Zhong Xi Yi Jie He Xue Bao (Journal of Chinese Integrative Medicine) 4 1 (2006) 1-6 [in Chinese with English abstract]
43. Bian Z.X., Li Y.P., Moher D., Dagenais S., Liu L., Wu T.X., et al. Improving the quality of randomized controlled trials in Chinese herbal medicine. Part I. Clinical trial design and methodology. Zhong Xi Yi Jie He Xue Bao (Journal of Chinese Integrative Medicine) 4 2 (2006) 120-129 [in Chinese with English abstract]
44. Gagnier J.J., Boon H., Rochon P., Moher D., Barnes J., Bombardier C., et al. Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration. Journal of Clinical Epidemiology 59 11 (2006) 1134-1149
45. McCarthy M. Critics slam draft WHO report on homoeopathy. Lancet 366 9487 (2005) 705-706
46. Global Programme on Evidence for Health Policy, World Health Organization: guidelines for WHO guidelines. EIP/GPE/EOC/2003.1.
47. Krumholz H.M. Guideline recommendations and results: the importance of the linkage. Annals of Internal Medicine 147 5 (2007) 342-343
48. Michie S., Berentson-Shaw J., Pilling S., Dieppe P., Raine R., Cluzeau F., et al. Turning evidence into recommendations: protocol for a study of guideline development groups. Implementation Science 2 1 (2007) 29
49. Murray C.J., Laakso T., Shibuya K., Hill K., and Lopez A.D. Can we achieve Millennium Development Goal 4? New analysis of country trends and forecasts of under-5 mortality to 2015. Lancet 370 9592 (2007) 1040-1054
50. Schunemann H.J., Hill S.R., Kakad M., Vist G.E., Bellamy R., Stockman L., et al. Transparent development of the WHO rapid advice guidelines. PLoS Medicine 4 May (5) (2007) 786-793